To address seemingly contradictory reports in colorectal cancer, Han et al. [81] stratified patients according to treatment status and found that high Beclin-1 expression was associated with reduced survival in the patients who received chemotherapy, while among the patients without chemotherapy, high Beclin-1 levels were associated with longer overall survival. Here, BECN1 is linked to colorectal cancer.